title: Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
authors.forename: Fatih
authors.initials: F
authors.lastname: Ermis
authors.forename: Sadakat
authors.initials: S
authors.lastname: Ozdil
authors.forename: Filiz
authors.initials: F
authors.lastname: Akyüz
authors.forename: Binnur
authors.initials: B
authors.lastname: Pinarbasi
authors.forename: Zeynel
authors.initials: Z
authors.lastname: Mungan
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000175:diagnosis; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D017511:Pyoderma Gangrenosum / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab